Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Neorich Biopharma Tech Co's Days Inventory or its related term are showing as below:
PHBID's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.975 * Ranked among companies with meaningful Days Inventory only.
Neorich Biopharma Tech Co's Days Inventory
stayed the same
from Jun. 2022 (0.00) to Jun. 2023 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Neorich Biopharma Tech Co's Inventory Turnover for the
three
months ended in Jun. 2023 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Neorich Biopharma Tech Co's Inventory-to-Revenue for the
three
months ended in Jun. 2023 was 9.50.
Neorich Biopharma Tech Co (OTCPK:PHBID) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Neorich Biopharma Tech Co's Inventory Turnover for the
three
months ended in Jun. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Neorich Biopharma Tech Co's Inventory to Revenue for the
three
months ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Neorich Biopharma Tech Co Days Inventory Related Terms
Neorich Biopharma Tech Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHBID vs DVLP, CSTF, BLMS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Neorich Biopharma Tech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neorich Biopharma Tech Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neorich Biopharma Tech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Neorich Biopharma Tech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neorich Biopharma Tech Co (PHBID) has a Days Inventory of 0.00 as of Jun. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Neorich Biopharma Tech Co and its competitors.
Is Neorich Biopharma Tech Co's Days Inventory too high?
Neorich Biopharma Tech Co's current Days Inventory is 0.00.
How does Neorich Biopharma Tech Co's Days Inventory compare to DVLP and CSTF?
Neorich Biopharma Tech Co's Days Inventory of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.98, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Neorich Biopharma Tech Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neorich Biopharma Tech Co's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neorich Biopharma Tech Co stock overvalued right now?
Neorich Biopharma Tech Co (PHBID) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Neorich Biopharma Tech Co (PHBID), the current Days Inventory is 0.00 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHBID has been successfully added to your 
